Price Chart

Profile

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
URL https://www.roche.com
Investor Relations URL https://www.roche.com/investors.htm
HQ State/Province N/A
Sector Healthcare
Industry Drug Manufacturers - General
Equity Style Large Cap/Blend
Next Earnings Release Jul. 26, 2024 (est.)
Last Earnings Release Feb. 01, 2024
Next Ex-Dividend Date Mar. 14, 2024
Last Ex-Dividend Date Mar. 16, 2023

Profile

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
URL https://www.roche.com
Investor Relations URL https://www.roche.com/investors.htm
HQ State/Province N/A
Sector Healthcare
Industry Drug Manufacturers - General
Equity Style Large Cap/Blend
Next Earnings Release Jul. 26, 2024 (est.)
Last Earnings Release Feb. 01, 2024
Next Ex-Dividend Date Mar. 14, 2024
Last Ex-Dividend Date Mar. 16, 2023